The Challenge of Change - Managing Excipients Control
Colorcon
28-Oct-2004 - Dutch group DSM slightly increased sales of pharma products during the third quarter but continued losses from its DSM Anti-Infectives division halved the Life Sciences operating profit.
27-Oct-2004 - Cardinal Health reported its long-delayed fourth-quarter financial results yesterday, revealing a hike in profit and revenues for the three months to end June, but lowered guidance for the first half of this fiscal year.
27-Oct-2004 - A report focusing on the pharmaceutical and biotechnology markets in Europe has singled out high throughput screening (HTS) as an approach that will provide mechanistic insights and new drug leads with improved efficiency whilst reducing cost.
27-Oct-2004 - More than half of pharmaceuticals outsourced at least 20 per cent of their ADMET (absorption, distribution, metabolism, excretion and toxicology) studies in 2003, according to a new market research report looking at outsourcing in the sector.
25-Oct-2004 - India is gearing up for the introduction of new legislation on intellectual property that will bring it into line with its World Trade Organisation commitments.
25-Oct-2004 - Swiss biopharmaceuticals company BioPartners has filed its first application in Europe for a generic version of interferon alpha, a biological drug. If approved, the 'biosimilar' could be on the market as early as next year.
25-Oct-2004 - The growing loss of patent protection on blockbuster drugs over the next few years and the rising need to contain spiralling healthcare costs are going to lend significant impetus to the growth of Europe's generics and biogenerics market, says a new report.
25-Oct-2004 - Novis, now with almost half a million readers, last week earned broad industry recognition with two further publishing awards, following on from its best publication prize earlier this year.
22-Oct-2004 - After over fifteen years of consolidation, the pharmaceutical industry may have reached a 'steady state', or even be facing future fragmentation.
21-Oct-2004 - A marriage between US chemicals group Rockwood Specialities and French separations specialist Novasep will create a unique company to serve the life sciences industry, according to the two companies.
21-Oct-2004 - Dutch chemicals and drugs group Akzo Nobel saw its net income accelerate in the third quarter of this year, to the surprise of analysts and investors, and helped by cost reductions and a big gain from the divestment of its coatings business.
20-Oct-2004 - This week's announcement of the US approval for an implantable radiofrequency identification (RFID) chip for use in humans as a prescription device has been met with consternation by a consumer group, which fears the technology could infringe civil liberties.
20-Oct-2004 - Bristol-Myers Squibb has reported encouraging data from two late-stage trials of a new drug for rheumatoid arthritis, abatacept, the first in a new class of T cell costimulation modulators.
19-Oct-2004 - A study performed at Tufts University in the US, commissioned by the Nordic Council of Ministers, has downplayed the impact of the controversial REACH legislation on the European chemicals industry.
18-Oct-2004 - Spanish pharmaceutical company Lacer has unveiled a new investment programme at a plant in Barcelona that will dramatically increase its production capacity.
18-Oct-2004 - The US Food and Drug Administration this week approved the first implantable radiofrequency identification microchip for human use, elevating RFID from a tool for supply chain management into an enabling technology for improving healthcare delivery to patients.
15-Oct-2004 - Serologicals has completed its acquisition of Upstate Group, acquiring the privately held company for $205 million (€166m) in cash ($102.5m) and stock.
14-Oct-2004 - In-Pharmatechnologist's periodic round up of personnel moves in the pharmaceutical sector includes a crop of new chief executives and senior managers across the pharmachem, drug delivery and biomanufacturing sectors.
14-Oct-2004 - The older generation is leading the consumption of nutritional supplements in the US and the aging baby boomers are the population to invest in, according to a new report, that also shows the supplement industry is now firmly in the hands of pharma giants.
13-Oct-2004 - Laborium Biopharma and the Biotechnology Research Institute of the National Research Council (BRI-NRC) have entered into an alliance, further boosting the biomanufacturing sector of Montreal in Quebec, Canada.
13-Oct-2004 - AstraZeneca has suffered another disappointment in its late-stage pipeline, with the news that the filing for approval of Galida (tesaglitazar), its new drug for diabetes, will be delayed by the need to carry out more studies.
11-Oct-2004 - Engineering firm AK Pharmaceuticals is to open a new Engineering Centre of Excellence in Ireland, in a move that reaffirms the healthy position of the Irish pharmaceutical industry. The move is set to create 220 new jobs over the next three years.
11-Oct-2004 - Stellar Biotechnologies has been awarded $3 million (€2 million) for the development of production methods, quality standards, and facilities for its Keyhole Limpet Hemocyanin (KLH), a key component of its anti-cancer vaccine.
08-Oct-2004 - According to a latest report, the growth of the biotechnology company will continue to outpace that of pharmaceutical companies, with the seven largest biotechnology companies growing at rates faster than the pharmaceutical industry's 9.1 per cent average.
07-Oct-2004 - Dutch biotechnology company Crucell has initiated legal proceedings against CEVEC Pharmaceuticals, which claims the company has violated Crucell's PER.C6 technology's European patent.